Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001760460-23-000002
Filing Date
2023-05-18
Accepted
2023-05-18 20:50:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2884
  Complete submission text file 0001760460-23-000002.txt   4589
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36845 | Film No.: 23937757
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 THIRD AVENUE FL 25 NEW YORK NY 10022
Business Address 950 THIRD AVENUE FL 25 NEW YORK NY 10022 2128783702
Puissance Life Science Opportunities Fund VI (Reporting) CIK: 0001760460 (see all company filings)

EIN.: 320567422 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144